Rheumnow

JAK-pot! How fast do DMARDs work?:Dr. Mike Putman and Dr. Kim Lauper Paraoxonase-1: Possible Biomarker for Progression to RA:Dr. Jonathan Kay Potential Impact of Weight Loss Drugs in Rheumatic Diseases:Dr. Arthur Kavanaugh PREDICT-SpA: Evaluating the influence of gender on disease assessment tools:Dr. Sheila Reyes SELECT-GCA: Upadacitinib in Giant Cell Arteritis:Dr. Mike Putman Too Many CAR-Ts for Horses?:Dr. Pope Transplant-free Survival Predictors in Idiopathic Inflammatory Myopathies-ILD:Dr. Gaby Martinez

A New ACR:Dr. Cush Are we under-monitoring in scleroderma ILD?:Dr. Janet Pope Cancer Survival in RA:Dr. Eric Dein interviews Joshua Hsieh Continuing or Stopping Low Dose Glucocorticoids in GPA:Dr. Mike Putman  COVID Associated Immune Disease:Dr. Len Calabrese How to Master ACR Meetings:Dr. Cush

ACR 2024 starts tomorrow; here are a few previews of Abstracts to be presented. Along with my recommendations of sessions you don’t want to miss.  

Dr. Jack Cush reviews the news and journal reports from this past week from RheumNow.com

Minimizing steroid use in patients with SLE. Learn more about when, why, and how to taper steroids and listen to experts, Dr Michelle Petri and Dr Leanna Wise, discuss key data and their clinical perspectives on these topics. 

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com Register now for RheumNow.live 2025

This week, Jonathan is joined by John J Cush, from Dallas, Texas, USA. The two doctors explore novel treatment avenues for rheumatic diseases, and discuss the exciting potential of AI and telemedicine.

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. Todays reports suggest where to look for help, especially with regard to pain.  

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com -- This weeks rants include the microbiome, PsA treatment choices and fishing for P-values in research.

Rheumatologists Dr. Jeffrey Curtis and Dr. Jon Giles discuss the risk of comorbidities that can occur as a consequence of uncontrolled inflammation in RA

Dr. Jack Cush reviews the regulatory approvals, announcements, guidelines and interesting journal articles from the past week on RheumNow.com.  When not to use muscle relaxants, how frequent is loneliness in RA/PsA/SpA and when to refer patients with Still's disease.. Register for RheumNow Live Feb 8 & 9th 2025 here  "Great Rheums go to Phenomenal Meetings like this"!

Dr. Jack Cush reviews the news, journal articles and a new FDA approval for EGPA, this week on the Podcast.

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week with a focus on fingers and better prescriptive follow through.

Learn about the importance of reducing organ damage and corticosteroid-associated toxicity in SLE, and how biologics may help to change the course of the disease by targeting its underlying mechanisms.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com - including tips on steroids, MAS, and myositis testing.  

Dr. Jack Cush picks highlight reports from the past week on RheumNow.com, with reports on the challenge of lupus nephritis, perplexing skin issues, you don't know JAK (about Tyk) and the value of a good family history.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com, noting his concerns about diet, cancer, ILD, death and dosing challenges.